Skip to main content
. 2019 Nov 22;11(6):1149–1162. doi: 10.1111/os.12577

Table 3.

Patients' clinical outcomes at mean follow‐up of 57.18 months

Clinical outcomes Overall 41‐B 41‐C P *
ROM, mean (SD) 117.4 (10) 118.7 (8.9) 115.0 (11.9) 0.012
VAS, mean (SD) 2.9 (2.2) 2.8 (2.3) 3.0 (2.0) 0.5150
AKSS score, mean (SD) 79.0 (16.1) 81.8 (15.7) 73.4 (15.8) 0.0166
Excellent, number (%) 23 (51) 17 (56.7) 6 (40.0)
Good 5 (11) 2 (6.7) 3 (20.0)
Fair 10 (22) 8 (26.7) 2 (13.3)
Poor 7 (16) 3 (10) 4 (26.7)
KOOS score, mean (SD) 69 (20.1)
Symptoms 77.2 (22.2) 81.2 (19.0) 69.0 (26.3) 0.0807
Pain 82.1 (16.2) 82.6 (16.9) 80.9 (15.1) 0.3984
ADL 82.0 (18.5) 83.1 (20.1) 79.9 (15.1) 0.0914
Sport/Recreation 47.1 (33.5) 47.7 (34.3) 45.7 (33) 0.3257
QoL 55.8 (28.6) 58.9 (30.2) 49.6 (24.8)

0.0243

SF‐36, mean (SD)
PCS 41.4 (11.2) 42.2 (11.9) 48.3 (11.0) 0.0198
MCS 47.4 (11.5) 39.7 (9.9) 45.6 (12.5) 0.3270
*

P was calculated comparing radiographic outcomes of 41‐B with 41‐C fractures after adjustment for age confounder (ANOVA).

AKSS, American Knee Society score; KOOS, knee injury and osteoarthritis outcome score; ROM, range of motion in degrees; SD, standard deviation; SF‐36, 36‐Item Short Form Survey; VAS, visual analog score.